Pharmacoeconomic issues in bisphosphonate treatment of metastatic bone disease

• 31 August 2001
• journal article
• review article
• Published by Elsevier in Seminars in Oncology
• Vol. 28, 64-68
• https://doi.org/10.1016/s0093-7754(01)90235-0

Abstract

Keywords

• CANCER
• TREATMENT
• SURVIVAL
• BONE
• BISPHOSPHONATE
• SKELETAL
• PHARMACOECONOMIC
• BENEFIT
• MODELED
• CURRENT COST